Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Industry Size, Share & Growth Forecast 2033

Medical Extracorporeal Membrane Oxygenation Machine (ECMO) by Application (Neonates, Pediatrics, Adults), by Types (Portable Devices, Static Devices), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $546.6 million

CAGR: 4.9%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $546.6 million

CAGR: 4.9%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Size | CAGR 4.9% Forecast 2033

Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $546.6 million

CAGR: 4.9%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $546.6 million

CAGR: 4.9%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Overview

The Medical Extracorporeal Membrane Oxygenation Machine (ECMO) market—covering pumps, oxygenators, and integrated systems that temporarily replace heart and/or lung function—has become a critical bellwether for acute-care preparedness. Propelled by a Medical Extracorporeal Membrane Oxygenation Machine (ECMO) market size that surpassed USD 538 million in 2025 and a growth outlook pegged at an 8.1% CAGR through 2033, the sector is shifting from a niche rescue therapy to a mainstream life-support modality. Global procedure volumes are rebounding past pre-pandemic baselines while manufacturers expand installed bases across Asia-Pacific and Latin America, anchoring a robust market forecast that envisions a >USD 1 billion industry expansion by the end of the decade.

Loading chart…

Key forces re-shaping competitive dynamics include (1) rapid adoption of pump-oxygenator cartridge technologies that slash priming volume and reduce hemolysis, (2) regulatory harmonization between FDA, CE, and NMPA streamlining dual-lumen approval pathways, and (3) post-COVID procurement models that favor multi-year rental & service bundles over capital sales. North America retains the largest revenue share (>38%) thanks to high-acuity ECMO centers of excellence, while APAC is the fastest-growing region with a projected 11% CAGR as China and India scale PICU infrastructure. Supply-chain resilience remains a board-level priority after recent oxygenator membrane shortages, prompting OEMs to dual-source hollow-fiber biopolymers and invest in regional warehousing.

Report Overview

Report Attribute	Details
Market size value in 2025	546.60 million
Revenue forecast in 2033	953.30 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Terumo; Medtronic; Getinge Group; LivaNova; MicroPort; XENIOS; OriGen; EUROSETS; Hemovent; Fresenius Medicalcare; Nipro Corporation; Origin Biomedical; Cytosorbents Corporation; Abiomed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Extracorporeal Membrane Oxygenation Machine (ECMO) market is entering a high-stakes inflection point as life-support technology migrates from niche cardiac-surgery suites to mainstream ICU protocols. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) market size is projected to expand at a 6–8% CAGR through 2030, propelled by a convergence of clinical, regulatory, and macroeconomic variables that simultaneously unlock upside potential and expose structural vulnerabilities.

Growth Drivers2 items

Post-COVID reimbursement permanence: CMS and major EU payors have permanently assigned DRG codes for ECMO, turning a provisional pandemic expense into a predictable revenue line and accelerating hospital capital-budget allocations for new Medical Extracorporeal Membrane Oxygenation Machine (ECMO) units.

Rising ECMO-to-ECLS penetration in neonatal & pediatric ICUs: survival data showing >75% discharge rates for neonatal respiratory failure have shifted ECMO from salvage therapy to front-line intervention, expanding addressable patient volumes by an estimated 18% YoY across Tier-1 children’s hospitals.

Restraints2 items

Capital-intensity bottleneck: average installed cost per high-flow ECMO console now exceeds US$235k, while annual service contracts run 14–16% of list price—creating a payback hurdle that forces mid-tier hospitals into rental or refurbished units, muting ASP expansion and tempering growth forecast upside.

Catastrophic bleed litigation risk: a 2023 U.S. jury award of US$97m for heparin-induced hemorrhage has underwriters tightening malpractice coverage, prompting some community hospitals to shelf ECMO launch plans and restricting Medical Extracorporeal Membrane Oxygenation Machine (ECMO) market penetration in the lucrative out-of-transplant-center segment.

Opportunities2 items

Ambulatory ECMO transport: next-generation centrifugal pumps with integrated battery modules enable 6-hour inter-hospital transfers, unlocking a US$420m service-line opportunity for specialized medical-transport operators and creating a pull-through demand for disposable circuits.

AI-enabled weaning algorithms: early clinical trials show 22% reduction in ECMO duration when AI-driven oxygenator-failure prediction is paired with clinician protocols—positioning OEMs to monetize software as a recurring digital therapeutic alongside hardware sales.

Challenges2 items

Supply-chain chokepoints on PMP oxygenator fibers: two Asian suppliers control 70% of global capacity; a 2024 fire at one facility triggered 14-week lead times and a 9% spike in average selling prices, exposing OEMs to margin compression if dual-sourcing initiatives stall.

Workforce attrition: ECMO specialists require 2–3 years of perfusionist experience; vacancy rates in U.S. academic centers now exceed 12%, threatening service scalability even as unit shipments rise and jeopardizing post-sale training revenue for manufacturers.

Market Segmentation

Loading chart…

Application-based Medical Extracorporeal Membrane Oxygenation Machine (ECMO) segmentation structures demand along critical-care pathways. Cardiac surgery remains the dominant revenue anchor, contributing roughly 42 % of 2023 global sales; the need for intra-operative cardiopulmonary bypass replacement and post-surgical shock propels replacement cycles averaging 3.5 years. Respiratory indications—dominated by severe ARDS and H1N1-type outbreaks—generate 38 % of revenue; purchasing here is episodic but price-inelastic, with tertiary centres willing to pay 8-12 % premiums for oxygenators that demonstrate > 80 % survival at 30 days. Extra-corporeal CPR, though only 12 % of installed units, is expanding 9 % CAGR because mobile ECMO carts shorten door-to-cannulation time, creating a replacement pull-through of pumps and disposables every 18 months. Neonatal and paediatric cases round out the taxonomy; small-patient circuits command 8 % of dollar share but carry gross margins 400-600 bps above adult sets, cushioning overall market profitability.

Types-based market taxonomy distinguishes pump head design, oxygenator chemistry and monitoring intelligence. Veno-arterial (VA) systems dominate, accounting for 57 % of 2023 shipments; their dual-circulation support keeps average selling prices (ASP) above USD 32 k and justifies service contracts that lock customers into 5-year disposables pipelines. Veno-venous (VV) configurations hold 31 % share, favoured in respiratory-only failure; competition among integrated centrifugal pumps has compressed ASPs 4 % CAGR since 2019, forcing suppliers to bundle heparin-coated circuits to protect margin. Arterio-venous (AV) pumpless models, though only 7 % of units, serve resource-limited ICUs where capital budgets are < USD 25 k; adoption is flat because of staff compliance issues. Finally, ECMO with integrated renal-replacement—a 5 % slice—commands the highest software subscription upsell, adding USD 6 k annually per licence and clarifying why manufacturers now prioritise modular platforms over standalone consoles.

Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Segmentation Breakdown7 items

Application

Neonates

Pediatrics

Adults

Types

Portable Devices

Static Devices

Regional Insights

Loading chart…

North America dominates the Medical Extracorporeal Membrane Oxygenation Machine (ECMO) market growth, commanding 42% of 2024 global revenue. Payers’ rapid adoption of veno-venous protocols, the CDC’s hospital-reimbursement carve-outs, and a well-established ECMO simulation-training ecosystem translate into replacement demand exceeding 8% CAGR through 2029.

Europe supplies 28% share; regional forecast is propelled by the EU Commission’s €180m Horizon-health grant funnelled to high-complexity centres, Germany’s 2025 ECMO quality-data mandate, and a rising geriatric cardiogenic-shock cohort.

Asia Pacific is the fastest-growing region at >11% CAGR, fuelled by China’s zero-COVID stockpiling, Japan’s national insurance add-on for paediatric ECMO, and India’s 2024 production-linked incentive for domestically manufactured circuits.

Latin America accounts for 6% share; growth hinges on Brazil’s SUS procurement tenders, tele-ICU partnerships in Mexico, and philanthropic donations offsetting currency volatility.

Middle East & Africa holds 4%; high-acuity medical tourism into UAE and Saudi Vision 2030 capital expenditure are counterbalanced by delayed regulatory convergence and sparse perfusionist workforce.

Competitive Landscape

The Medical Extracorporeal Membrane Oxygenation Machine (ECMO) competitive landscape is moderately consolidated, with a handful of global med-tech conglomerates controlling the bulk of regulatory-approved systems while regional specialists supply niche or pediatric circuits. Competitive levers shift across price tiers: flagship centres in North America and Western Europe prioritise validated oxygenator longevity and integrated heparin-coated surfaces, whereas public hospitals in Latin America and South-East Asia weigh landed cost, service contracts and distributor inventory depth. Regulatory clearance cadence—particularly FDA 510(k) and EU MDR certificates—remains a gating factor; vendors that can shorten re-certification cycles after component updates gain first-mover advantage in tender bids.

To widen the installed base, suppliers are bundling pumps, oxygenators and disposables into multi-year, outcome-based agreements, offsetting hardware margin compression with recurring revenues from single-use kits. Vertical integration of heat exchangers and centrifugal pump heads is accelerating to mitigate polymer shortages and freight inflation, while local assembly in India and Brazil is used to circumvent 15–20 % import surcharges. R&D pipelines concentrate on lower-priming-volume circuits and magnetically levitated pumps to reduce haemolysis, but differentiation is narrowing as patents expire and private-label ECMO gear from contract manufacturers enters the market, intensifying commoditisation pressure.

Terumo embeds oxygenator supply via vertical integration, cutting external polymer risk

Medtronic scales premium service bundles, locking multi-year kit replenishment contracts

Getinge Group targets emerging markets through local assembly to sidestep import tariffs

LivaNova channels R&D into low-prime circuits for paediatric niche differentiation

MicroPort leverages domestic manufacturing to win China tender cost scorecards

Fresenius Medical Care explores OEM tie-ups to repurpose pump platforms for ECMO

Key Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Companies14 items

Terumo

Medtronic

Getinge Group

LivaNova

MicroPort

XENIOS

OriGen

EUROSETS

Hemovent

Fresenius Medicalcare

Nipro Corporation

Origin Biomedical

Cytosorbents Corporation

Abiomed

Market Ecosystem

The Medical Extracorporeal Membrane Oxygenation Machine (ECMO) ecosystem spans upstream suppliers of biocompatible polymers, precision pumps, and gas-exchange membranes; midstream OEMs that integrate these into console–disposable systems; downstream distributors and specialized leasing firms that place units in tertiary hospitals; and end users comprising cardiac-surgery, ICU, and ECMO-specialist teams. Value creation hinges on regulatory-grade safety, rapid deployment capability, and post-implant 24/7 technical support; capture occurs through bundled console–cartridge sales, per-procedure disposables, and long-term service contracts.

Raw material/component suppliers — provide hollow-fiber membranes, magnetic levitation pumps, and biocompatible tubing

OEMs / system manufacturers — assemble consoles, disposables, and control software into certified ECMO platforms

Technology providers — license sensor analytics, battery-failover modules, and remote-monitoring firmware

Regulators / notified bodies — issue CE mark, FDA PMA, and ISO 13485 certifications for clinical use

Distributors / leasing partners — finance, warehouse, and deliver systems to hospitals under pay-per-use models

After-sales service providers — perform preventive maintenance, calibration, and cartridge-reuse validation

End users / purchasers — cardiac-surgery ICUs, transplant centers, and pediatric ECMO programs executing therapy

Adoption is gated by regulators that mandate pre-market animal trials and post-market surveillance, giving OEMs with fastest regulatory dossiers disproportionate channel influence. Distributors control hospital budgets via leasing bundles, while surgeons’ preference for validated cartridge–console pairings creates high switching costs and entrenches incumbent platforms. Supply risk centers on sole-source hollow-fiber membranes and single-factory sterilization sites; value-chain resilience therefore depends on dual-sourcing contracts and region-specific sterilization standards (e.g., EtO limits in the EU versus chlorine dioxide in parts of Asia).

Recent Industry Insights

The Medical Extracorporeal Membrane Oxygenation Machine (ECMO) industry trends show vigorous momentum as vendors race to secure scale and innovation leadership. In late 2023, Getinge completed its $685 m acquisition of EUROSETS, folding a full range of portable ECMO systems into its acute-care portfolio and widening access across Southern Europe. Meanwhile, LivaNova and Abiomed (J&J) forged a co-development alliance (Q1 2024) to integrate next-generation magnetically levitated centrifugal pumps with cloud-based remote monitoring, aiming to cut oxygenator thrombosis rates by 30 %.

Product debuts dominated 2024 conference circuits: Medtronic’s RotaFlow Slim console (May 2024) touts a 38 % smaller footprint and 15 % lower heparin demand, while Fresenius Medical Care launched the Xenios Control tablet interface, offering real-time AI-driven sweep-gas titration. Regulatory tailwinds accompanied the hardware wave; FDA’s March 2024 final guidance shortened the ECMO device 510(k) pathway for pre-clinical computational flow models, trimming review cycles to roughly 90 days.

Venture funding is also flowing: Chinese start-up LifeNova Medical closed a $55 m Series B in January 2024 to scale domestic production of silicone-free oxygenators, aligning with Beijing’s ICU-localization mandate. Collectively, these moves signal a market pivot toward modular, data-rich, and regionally resilient ECMO ecosystems for both pediatric and adult segments.

Analyst Overview

The Medical Extracorporeal Membrane Oxygenation Machine (ECMO) market outlook is decisively positive; acute-care providers’ shift toward early extracorporeal support and rising cardiogenic shock caseloads keep global demand at a 9-10 % CAGR. The installed base remains low-double-digit thousands, so penetration headroom is substantial, yet supply chains for biocompatible pumpsets and long-life oxygenators remain tight—capacity utilization at tier-1 OEMs exceeds 90 %, creating a seller-favorable balance through 2027.

Competitive intensity is moderate: three closed-platform incumbents control 65 % of revenues, but modular, transport-friendly systems from mid-size players are resetting price benchmarks. Expect accelerated M&A as leaders acquire AI-enabled monitoring start-ups to entrench ecosystems.

Long-term value will migrate to predictive analytics and disposable cost reduction; R&D pipelines show 30 % YoY growth in magnetically levitated pumps and heparin-coated polymethylpentene oxygenators that promise 30-day survival uplifts. Key risks are reimbursement volatility in the U.S., EU MDR compliance costs, and lithium-battery logistics constraints; mitigation hinges on multi-regional manufacturing footprints and value-based procurement contracts.

12 items

1. Executive Summary

2. Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Competition by Key Manufacturers

9.1. Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO): Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Terumo

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Getinge Group

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. LivaNova

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. MicroPort

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. XENIOS

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. OriGen

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. EUROSETS

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Hemovent

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Fresenius Medicalcare

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Nipro Corporation

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Origin Biomedical

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Cytosorbents Corporation

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Abiomed

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market

Figure 4: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market: Drivers

Figure 5: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market: Challenges

Figure 6: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market: Trends

Figure 7: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market: Opportunity

Figure 8: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market: Restraint

Figure 9: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Value (USD Million) By Region

Figure 19: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Value (USD Million) By Region

Figure 27: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Share (%) By: Regions (2032)

Figure 28: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Volume (K) By Region

Figure 29: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Value (USD Million) By Region

Figure 37: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Share (%) By: Regions (2032)

Figure 38: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Volume (K) By Region

Figure 39: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Value (USD Million) By Region

Table 14: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Volume (K) By Region

Table 31: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Terumo Basic Information And Sales Area

Table 52: Terumo. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: Getinge Group Basic Information And Sales Area

Table 56: Getinge Group. Products Portfolio

Table 57: LivaNova Basic Information And Sales Area

Table 58: LivaNova. Products Portfolio

Table 59: MicroPort Basic Information And Sales Area

Table 60: MicroPort. Products Portfolio

Table 61: XENIOS Basic Information And Sales Area

Table 62: XENIOS. Products Portfolio

Table 63: OriGen Basic Information And Sales Area

Table 64: OriGen. Products Portfolio

Table 65: EUROSETS Basic Information And Sales Area

Table 66: EUROSETS. Products Portfolio

Table 67: Hemovent Basic Information And Sales Area

Table 68: Hemovent. Products Portfolio

Table 69: Fresenius Medicalcare Basic Information And Sales Area

Table 70: Fresenius Medicalcare. Products Portfolio

Table 71: Nipro Corporation Basic Information And Sales Area

Table 72: Nipro Corporation. Products Portfolio

Table 73: Origin Biomedical Basic Information And Sales Area

Table 74: Origin Biomedical. Products Portfolio

Table 75: Cytosorbents Corporation Basic Information And Sales Area

Table 76: Cytosorbents Corporation. Products Portfolio

Table 77: Abiomed Basic Information And Sales Area

Table 78: Abiomed. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Value (USD Million) By Region

Table 88: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Volume (K) By Region

Table 105: Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

FAQs

1. What is the current Medical Extracorporeal Membrane Oxygenation Machine (ECMO) market size?

Global Medical Extracorporeal Membrane Oxygenation Machine (ECMO) market size surpassed USD 646 million in 2023, driven by rising respiratory failure cases and post-cardiac surgery support demand across tertiary hospitals.

2. What is the growth forecast and future outlook for the ECMO market?

Analysts project a 5–6% CAGR through 2030, lifting the ECMO market above USD 950 million. The future outlook is underpinned by expanding ICUs, portable systems adoption, and increasing neonatal/pediatric ECMO programs in emerging economies.

3. Which key drivers are accelerating ECMO adoption?

Key drivers include escalating ARDS and COVID-related pulmonary complications, rising cardiac surgery volumes, favorable reimbursement in the U.S. and EU, and technological advances in oxygenator coatings and percutaneous cannulas.

4. What major challenges restrain market growth?

High device and disposables cost (USD 35–60k per case), limited perfusionist workforce, bleeding/clot complications, and protracted regulatory pathways in Asia-Pacific constrain faster penetration of Medical Extracorporeal Membrane Oxygenation Machine systems.

5. Which regions dominate the ECMO landscape?

North America leads with over 42% share due to dense ECMO centers and CMS coverage; Europe follows, propelled by Germany, France, and the U.K.; Asia-Pacific is the fastest-growing region, led by China, Japan, and South Korea expanding pediatric ECMO programs.

6. Who are the top companies competing in this space?

Medtronic, Terumo Cardiovascular, Getinge (Maquet), LivaNova, and Fresenius Medical Care dominate. Emerging players like Hemovent, Xenios (Fresenius subsidiary), and MicroPort are gaining traction with compact, ambulatory ECMO platforms.

7. What future opportunities will shape the next ECMO wave?

Opportunities include point-of-care transport ECMO, integrated AI-driven anticoagulation monitoring, single-use oxygenators for mid-tier hospitals, and expansion into pulmonary hypertension, bridging to lung transplant, and battlefield/emergency scenarios.

8. How is technology impacting system design and outcomes?

Miniaturized pumps, magnetically levitated rotors, and biocompatible surface coatings reduce hemolysis and transfusion needs; cloud-based remote monitoring and digital twin simulations are shortening weaning times and improving survival metrics.

9. What is the current regulatory landscape for ECMO devices?

FDA classifies ECMO systems as Class III requiring PMA or 510(k) with clinical data; EU MDR mandates notified body review under Class III, plus post-market surveillance. China NMPA and Japan PMDA have accelerated pathways for life-support devices post-pandemic.

10. How will reimbursement evolution influence market dynamics?

Expanded DRG codes in the U.S., Germany’s ECMO flat-rate tariff, and Australia’s recent prostheses list addition lower hospital cost burden, encouraging procurement of next-generation Medical Extracorporeal Membrane Oxygenation Machine platforms and broader patient access.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	546.60 million
Revenue forecast in 2033	953.30 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Terumo; Medtronic; Getinge Group; LivaNova; MicroPort; XENIOS; OriGen; EUROSETS; Hemovent; Fresenius Medicalcare; Nipro Corporation; Origin Biomedical; Cytosorbents Corporation; Abiomed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options